Abstract
Osteoarthritis (OA) is characterized by the progressive degradation of articular cartilage. Recent evidence suggests that ferroptosis—an iron-dependent form of regulated cell death—plays a pivotal role in this process. This study demonstrates that knocking down Nuclear Protein 1 (Nupr1) inhibits ferroptosis in mouse chondrocytes, thereby delaying the pathological progression of OA in both cellular and animal models.
Introduction
Osteoarthritis remains a leading cause of global disability, yet current clinical interventions primarily focus on symptom management rather than disease modification. Ferroptosis, driven by the accumulation of iron and subsequent lipid peroxidation (the "rusting" of cell membranes), has emerged as a critical driver of cartilage loss. This research investigates whether Nupr1, a protein involved in cellular stress responses, acts as a regulatory switch for ferroptosis in chondrocytes.
Methodology
The study utilized a comprehensive experimental framework:
- In Vitro Model: Primary mouse chondrocytes were isolated and treated with IL-1β to simulate the inflammatory environment of an osteoarthritic joint. Small interfering RNA (siRNA) was employed to silence Nupr1 expression.
- In Vivo Model: OA was induced in 7-week-old C57BL/6J mice via Destabilization of Medial Meniscus (DMM) surgery. Nupr1 was targeted using an Adeno-associated virus (AAV5) to deliver short hairpin RNA (shRNA) directly into the joint.
- Detection Assays: The team used FerroOrange staining to monitor labile iron levels, C11-BODIPY for lipid peroxidation, and biochemical assays to measure malondialdehyde (MDA) and glutathione (GSH) levels.
Results and Discussion
Nupr1 as a Ferroptosis Regulator
The researchers identified that Nupr1 knockdown modulates the P53/SLC7A11/GPX4 axis. Silencing Nupr1 led to the downregulation of pro-ferroptotic factors like P53 and ACSL4, while simultaneously upregulating SLC7A11 and GPX4, the cell's primary antioxidant defenses against ferroptosis.
Therapeutic Impact in OA Models
In cellular assays, knocking down Nupr1 successfully "rescued" chondrocytes from IL-1β-induced death, evidenced by a significant decrease in MDA and a restoration of GSH levels ($P < 0.01$). In the animal model, AAV-mediated silencing of Nupr1 significantly improved OARSI scores, indicating better preservation of joint structure and reduced cartilage erosion compared to untreated OA groups ($P < 0.01$).
Conclusion
This study identifies Nupr1 as a critical driver of ferroptosis in osteoarthritis. By inhibiting the P53/SLC7A11/GPX4 axis, Nupr1 knockdown offers a protective effect against cartilage degradation. While clinical translation requires further investigation into species-specific differences and long-term safety, Nupr1 represents a promising therapeutic target for disease-modifying OA treatments.
Summary updated